Imaging of TSPO expression is a new approach for studying atherosclerotic lesion progression and inflammatory cell infiltration. The TSPO ligand, 18 F-PBR111, is a potential clinical diagnostic tool for the detection and quantification of atherosclerotic lesion progression in humans.
Background: Atherosclerosis is characterized by lipid deposition, monocyte infiltration and foam cell formation in the artery wall. Translocator protein (TSPO) is abundantly expressed in lipid rich tissues. Recently, TSPO has been identified as a potential diagnostic tool in cardiovascular disease. The purpose of this study was to determine if the TSPO ligand, 18 F-PBR111, can identify early atherosclerotic lesions and if TSPO expression can be used to identify distinct macrophage populations during lesion progression.
Methods and Results: ApoE -/mice were maintained on a high-fat diet for 3 or 12 weeks. C57BL/6J mice maintained on chow diet served as controls. Mice were administered 18 F-PBR111 intravenously and PET/CT imaged. After euthanasia, aortas were isolated, fixed and optically cleared. Cleared aortas were immunostained with DAPI, and fluorescently labelled with antibodies to-TSPO, the tissue resident macrophage marker F4/80 and the monocyte-derived macrophage marker CD11b. TSPO expression and the macrophage markers were visualised in fatty streaks and mature lesions by light sheet microscopy. While tissue resident F4/80 + macrophages were evident in the arteries of animals without atherosclerosis, no CD11b + macrophages were observed in these animals. In contrast, mature plaques had high CD11b and low F4/80 expression. A ~3-fold increase in the uptake of 18 F-PBR111 was observed in the aortas of atherosclerotic mice relative to controls.
Introduction
Atherosclerosis, a chronic inflammatory disease characterized by accumulation of lipids and inflammatory cells such as macrophage foam cells within the arterial wall, is a leading cause of death globally 1 . There is significant debate as to the relative contributions of tissue-resident versus monocyte-derived macrophages to atherosclerotic lesion progression 2 .
Atherosclerotic progression commonly develops as an indolent process over decades 3 , making early identification of the condition challenging. Clinical assessment of atherosclerosis currently involves either invasive angiography or intravascular ultrasound (IVUS), or is limited to recognition of advanced disease by, for example, calcium scoring 4 . Recent efforts have focused on establishing dynamic imaging approaches to identify clinically relevant atherosclerosis. The development, assessment and broad adoption of novel PET/CT techniques enables early detection and diagnosis of cardiovascular disease 5 . Non-invasive PET imaging, using specifically targeted radiolabelled probes to track active atherosclerosis may provide a highly suitable method to identify and further understand atherogenesis 6 . In this regard, translocator protein (TSPO) has recently been identified as a therapeutic target and diagnostic tool in cardiovascular disease 7 .
TSPO is an 18 kDa mitochondrial membrane protein that is involved in steroidogenesis and cholesterol transport 8 . It is expressed abundantly throughout the body, and is highly upregulated in microglia and macrophages during inflammation 9, 10 . Clinically, the TSPO radioligand 11 C-PK11195 has been used to image atherosclerotic lesions in the carotid artery 11 . However, use of this ligand was limited 4 due to uptake by healthy vessels. Newer TSPO ligands have been developed in recent years and 18 F-PBR111 has evolved as promising candidate owing to its higher affinity and binding specificity compared to 11 C-PK11195 12 . Moreover, as TSPO is involved in the regulation of cardiovascular, atherosclerotic and inflammatory processes, TSPO ligands are promising therapeutic and diagnostic tools for use in cardiovascular disease 7 . Treating macrophages with TSPO agonists has been shown to increase cholesterol efflux 13 and treatment of cholesterol fed guinea pigs and apoE -/mice with a peptide containing the cholesterol binding domain of TSPO reduced serum cholesterol levels and decreased atheroma formation 14 .
In this study, the ability of 18 F-PBR111 to detect atherosclerosis progression in vivo was examined. Specifically, the ability of 18 F-PBR111 to detect atherosclerotic lesions at different stages of development was investigated. It also asked if TSPO expression increases with disease progression and if distinct macrophage populations can be distinguished by TSPO expression during lesion development.
The findings of this study provide a rationale for the development of TSPO radioligands as clinical diagnostic tools for the detection and quantification of atherosclerosis in humans by non-invasive, biomedical imaging.
Methods
Mice. C57BL/6J and B6.129P2-Apoe tm1Unc (apoE -/-) mice were obtained from Animal Resources Centre (Perth, Australia) and maintained in pathogen-free conditions at the Brain and Mind Centre, University of Sydney. Control C57BL/6J mice were fed a standard chow diet, whilst apoE -/mice were maintained on a high fat diet (HFD; 22% fat, 0.15% cholesterol, Specialty Feeds, Perth, Australia) for the time periods stated. All procedures were approved by the University of Sydney Animal Ethics Committee and followed the NIH Guide for the care and use of laboratory animals, Eighth edition (2011).
Light sheet microscopy. Mice were euthanized after PET/CT scanning and aortas
were isolated and fixed overnight in 4% (v/v) paraformaldehyde. Lipid was cleared from the tissue as previously described 15 . Briefly, fixed tissues were incubated in then assessed for TSPO + volume, while aorta wall masks were used to calculate total aorta and aortic wall volumes. Using these masks, the standard deviation of TSPO channel intensity within the aorta wall was determined, and the ratio of standard deviation and average intensity calculated for each slice. In order to characterize the amount of cross correlation between TSPO and CD11b, image cross correlation spectroscopy was used 17 . The TSPO + and aorta wall masks Statistical analysis. All data presented are mean ± SD. Data was analysed using Prism 7 (GraphPad). One-way ANOVA or Kruskal-Wallis tests, as appropriate, were used to determine statistically significant differences between data sets. A p value < 0.05 was considered statistically significant.
Results

TSPO accumulates in atherosclerotic lesions
Aortas were rendered optically clear ( Fig. 1A) and stained with fluorescently labelled TSPO and DAPI antibodies. Expression of TSPO during atherosclerotic lesion development was determined in the cleared and immunostained aortas by 3D imaging using lightsheet fluorescence microscopy. TSPO expression was not observed in the aortas of control mice (Fig. 1B) , and was restricted to the vessel wall of aortas of 3-week HFD fed apoE -/mice (Fig. 1C ). 12-week HFD fed apoE -/mice showed high TSPO expression in both regions of mature plaque and fatty streaks lining the vessel wall ( Fig. 1D ). Quantification of TSPO + volume demonstrated a significant increase in 3-week HFD fed apoE -/mice compared to controls (0.64േ0.23% vs 0.04േ0.06% TSPO + volume for 3-week HFD and control, respectively; p<0.05). 12 weeks of HFD led to a further significant increase in TSPO + volume (34.05േ24.26% TSPO + volume; p<0.05 vs both control and 3-week groups) ( Fig. 1E ).
To better characterise the pattern of TSPO expression in the aortas of atherosclerotic mice, a masking algorithm was applied ( Fig. 2A) to determine a pixelbased intensiometric analysis on a per plane basis, and then calculated the standard deviation (SD) of the TSPO channel intensity within this pre-defined region of interest. These results show that the SD of the TSPO signal in the 12-week HFD fed apoE -/mice was significantly increased relative to both control and 3-week HFD mice (p<0.05 vs both) (Fig. 2B) .
TSPO is preferentially co-localized to CD11b+ macrophages
To investigate the presence of specific macrophage subpopulations throughout atherosclerotic lesion development, aortas were immunostained with the macrophage markers CD11b and F4/80. In aortas from control C57BL/6J mice (Fig.   3A ) and 3-week HFD fed apoE -/mice (Fig. 3B) , F4/80 + macrophages predominated, while CD11b staining was minimal. In contrast, significant CD11b staining was observed in the aortas of 12-week HFD fed apoE -/mice (Fig. 3C ). Co-localization of the respective macrophage markers and TSPO was determined by calculating the spatial image cross-correlation (ICCS) and expressing the results as the change in ICCS (TSPO/CD11b -TSPO/F4/80) ( Figure 3D ). High ICCS values, which are indicative of a high correlation between CD11b and TSPO levels, were observed in mature plaque (Fig. 3E ) and fatty streak (Fig. 3F) regions. TSPO expression was associated with CD11b expression, as evidenced by the positive ICCS values observed in the vast majority of slices.
F-PBR111 detects mature, but not early lesions in vivo
Given the level of expression and localisation of TSPO in the aortas of apoE -/mice maintained on HFD, it was next asked if the TSPO agonist 18 F-PBR111 could also detect atherosclerosis in these mice in vivo. To control for the level of circulating 18 F-PBR111, activity in the lateral tail vein was subtracted from the region of interest in the aorta (Fig. 4) . This allowed for the tissue specific uptake in the aorta to be measured. Uptake of 18 F-PBR111 in the aorta was significantly increased in 12-week high fat fed apoE -/mice compared to both 3-week HFD apoE -/and wildtype control mice (maximal activity at 2.7 min post injection; 9.15േ3.60 vs 0.77േ1.32 and 1.22േ1.20 %ID/cm 3 , for 12-week HFD, 3-week HFD and control mice, respectively;
Discussion
This study found that TSPO expression in aortas of high-fat fed apoE -/mice was progressively elevated with atherosclerotic lesion progression. These results were validated by PET/CT with increased uptake of the TSPO radioligand 18 F-PBR111 in mice with advanced atherosclerosis relative to mice with early stage disease and control mice without disease. It was also demonstrated that macrophage subpopulations differed between early atherosclerosis and more mature plaque regions. Whilst F4/80 + tissue resident macrophages were evident in aortas of animals without atherosclerosis, no CD11b staining was observed in the arteries of these mice. In contrast, atherosclerotic lesions had significantly increased CD11b expression that co-localized with TSPO.
Atherosclerosis is a leading cause of death globally and is now widely recognized as a lipid-driven, systemic inflammatory disease 19 . A critical initiating event in atherosclerosis is excessive lipid accumulation and foam cell formation within the artery wall, leading to activation of inflammatory signaling 20 . Macrophages and monocytes are the major immune cells in atherosclerosis and play important roles throughout all stages of lesion progression 21 . However, macrophage development is a highly heterogeneous process, and embryonically derived tissue resident macrophages can be joined or replaced by recruited monocytes upon inflammatory stimuli 19, 22 .
This study has shown that CD11b + macrophages predominate in advanced atherosclerotic lesions. Contrastingly, no CD11b staining was present and F4/80 + regions were evenly distributed throughout the aortas of control C57BL/6J mice and 13 early lesions in 3 weeks HFD-fed apoE -/mice. Thus, this data shows for the first time that TSPO accumulates in the same regions of atherosclerotic lesions as specific macrophage subpopulations. There is significant debate regarding the utility and specificity of markers to determine the lineage and source of the macrophages in vivo 23 . CD11b is expressed by newly migrating macrophages in the liver 24, 25 , whilst F4/80 is present on the surface of tissue resident macrophages in the spleen and liver 24 .
A challenge in clinical management is that most patients with atherosclerosis do not display overt disease-related symptoms. This also presents a substantial diagnostic challenge 26 . Recent developments have focused on a shift to novel, non-invasive techniques such as PET, coupled with CT or MRI to allow precise anatomical localization and characterisation of atherosclerotic lesions 6 . In agreement with previous studies, the results presented here demonstrate that TSPO may be a useful marker of atherosclerotic lesion development. Furthermore, the specific association of TSPO with CD11b warrants further investigation and may provide insights into plaque development, specifically relating to macrophage infiltration of the vessel wall.
In conclusion, this study provides evidence of the diagnostic potential of TSPO imaging as a means of studying atherosclerotic lesion progression. These results show TSPO expression in a distinct macrophage population that plays an important role in atherosclerotic lesion progression. There is thus a significant rationale for the development and use of radiolabelled TSPO ligands as tools for the detection and quantification of atherosclerotic lesion progression. 
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